HELENA IN'T VELD: Open Payments
NPI 1982071429 · AVONDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,427 in 68 payments from 14 companies in 2025. Trend: 2023 $18,347 · 2024 $22,576 · 2025 $8,427
Honoraria: $5,000Food & beverage: $1,675Consulting: $1,156Travel & lodging: $542Education: $54
| Company | Payments | Amount |
|---|---|---|
| QOL Medical, LLC | 19 | $5,902 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $1,156 |
| Janssen Biotech, Inc. | 11 | $427 |
| ABBVIE INC. | 12 | $268 |
| Aimmune Therapeutics, Inc. | 5 | $159 |
| Madrigal Pharmaceuticals | 3 | $110 |
| GENZYME CORPORATION | 3 | $110 |
| PFIZER INC. | 3 | $84 |
| Ardelyx, Inc. | 3 | $61 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
Products named: Sucraid, TREMFYA, RINVOQ, VOWST, REZDIFFRA, DUPIXENT, VELSIPITY, IBSRELA.
Industry payments across AZ — which companies pay providers there.
